• Users Online: 126
  • Print this page
  • Email this page

    Article Cited by others

ORIGINAL ARTICLE

Cytoplasmic expression, optimization and catalytic activity evaluation of recombinant mature lysostaphin as an anti-staphylococcal therapeutic in escherichia coli

Naderi Samaneh, Alikhani Mohammad Yousef, Karimi Jamshid, Shabab Nooshin, Mohamadi Nejad, Jaliani Hossein Zarei, Saidijam Massoud

Year : 2015| Volume: 2| Issue : 2 | Page no: 72-77

   This article has been cited by
 
1 High-Yield Production of Active Recombinant S. simulans Lysostaphin Expressed in E. coli in a Laboratory Bioreactor
Zeynep Efsun DUMAN,Aise ÜNLÜ,Hayriye ÜNAL,John M. WOODLEY,Baris BINAY
Protein Expression and Purification. 2020; : 105753
[Pubmed]  [Google Scholar] [DOI]
2 Cloning, Expression and One-Step Purification of a Novel IP-10-(anti-HER2 scFv) Fusion Protein in Escherichia coli
Maryam Ahmadzadeh,Farzaneh Farshdari,Mahdi Behdani,Leila Nematollahi,Elham Mohit
International Journal of Peptide Research and Therapeutics. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 Anti-HER2 scFv Expression in Escherichia coli SHuffle®T7 Express Cells: Effects on Solubility and Biological Activity
Maryam Ahmadzadeh,Farzaneh Farshdari,Leila Nematollahi,Mahdi Behdani,Elham Mohit
Molecular Biotechnology. 2019;
[Pubmed]  [Google Scholar] [DOI]
4 Enhanced production of recombinant Staphylococcus simulans lysostaphin using medium engineering
Zeynep Efsun Duman,Aise Ünlü,Mehmet Mervan Çakar,Hayriye Ünal,Baris Binay
Preparative Biochemistry and Biotechnology. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]

 

Read this article